446 related articles for article (PubMed ID: 28212562)
21. MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.
Lee HK; Bier A; Cazacu S; Finniss S; Xiang C; Twito H; Poisson LM; Mikkelsen T; Slavin S; Jacoby E; Yalon M; Toren A; Rempel SA; Brodie C
PLoS One; 2013; 8(2):e54652. PubMed ID: 23390502
[TBL] [Abstract][Full Text] [Related]
22. miR-504 modulates the stemness and mesenchymal transition of glioma stem cells and their interaction with microglia via delivery by extracellular vesicles.
Bier A; Hong X; Cazacu S; Goldstein H; Rand D; Xiang C; Jiang W; Ben-Asher HW; Attia M; Brodie A; She R; Poisson LM; Brodie C
Cell Death Dis; 2020 Oct; 11(10):899. PubMed ID: 33093452
[TBL] [Abstract][Full Text] [Related]
23. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
[TBL] [Abstract][Full Text] [Related]
24. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
[TBL] [Abstract][Full Text] [Related]
25. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.
Wang Z; Wang B; Shi Y; Xu C; Xiao HL; Ma LN; Xu SL; Yang L; Wang QL; Dang WQ; Cui W; Yu SC; Ping YF; Cui YH; Kung HF; Qian C; Zhang X; Bian XW
Oncogene; 2015 Mar; 34(11):1407-19. PubMed ID: 24704830
[TBL] [Abstract][Full Text] [Related]
27. The U2AF2 /circRNA ARF1/miR-342-3p/ISL2 feedback loop regulates angiogenesis in glioma stem cells.
Jiang Y; Zhou J; Zhao J; Zhang H; Li L; Li H; Chen L; Hu J; Zheng W; Jing Z
J Exp Clin Cancer Res; 2020 Sep; 39(1):182. PubMed ID: 32894165
[TBL] [Abstract][Full Text] [Related]
28. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH
Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
[TBL] [Abstract][Full Text] [Related]
30. Targeting A20 decreases glioma stem cell survival and tumor growth.
Hjelmeland AB; Wu Q; Wickman S; Eyler C; Heddleston J; Shi Q; Lathia JD; Macswords J; Lee J; McLendon RE; Rich JN
PLoS Biol; 2010 Feb; 8(2):e1000319. PubMed ID: 20186265
[TBL] [Abstract][Full Text] [Related]
31. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
[TBL] [Abstract][Full Text] [Related]
32. REST represses miR-124 and miR-203 to regulate distinct oncogenic properties of glioblastoma stem cells.
Marisetty AL; Singh SK; Nguyen TN; Coarfa C; Liu B; Majumder S
Neuro Oncol; 2017 Apr; 19(4):514-523. PubMed ID: 28040710
[TBL] [Abstract][Full Text] [Related]
33. Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells.
Aldaz B; Sagardoy A; Nogueira L; Guruceaga E; Grande L; Huse JT; Aznar MA; Díez-Valle R; Tejada-Solís S; Alonso MM; Fernandez-Luna JL; Martinez-Climent JA; Malumbres R
PLoS One; 2013; 8(10):e77098. PubMed ID: 24155920
[TBL] [Abstract][Full Text] [Related]
34. Expression and roles of Wilms' tumor 1-associating protein in glioblastoma.
Jin DI; Lee SW; Han ME; Kim HJ; Seo SA; Hur GY; Jung S; Kim BS; Oh SO
Cancer Sci; 2012 Dec; 103(12):2102-9. PubMed ID: 22957919
[TBL] [Abstract][Full Text] [Related]
35. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
36. miR-143 inhibits oncogenic traits by degrading NUAK2 in glioblastoma.
Fu TG; Wang L; Li W; Li JZ; Li J
Int J Mol Med; 2016 Jun; 37(6):1627-35. PubMed ID: 27081712
[TBL] [Abstract][Full Text] [Related]
37. Shift of microRNA profile upon orthotopic xenografting of glioblastoma spheroid cultures.
Halle B; Thomassen M; Venkatesan R; Kaimal V; Marcusson EG; Munthe S; Sørensen MD; Aaberg-Jessen C; Jensen SS; Meyer M; Kruse TA; Christiansen H; Schmidt S; Mollenhauer J; Schulz MK; Andersen C; Kristensen BW
J Neurooncol; 2016 Jul; 128(3):395-404. PubMed ID: 27063952
[TBL] [Abstract][Full Text] [Related]
38. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
Shin HJ; Lee S; Jung HJ
J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-29a activates a multi-component growth and invasion program in glioblastoma.
Zhao Y; Huang W; Kim TM; Jung Y; Menon LG; Xing H; Li H; Carroll RS; Park PJ; Yang HW; Johnson MD
J Exp Clin Cancer Res; 2019 Jan; 38(1):36. PubMed ID: 30683134
[TBL] [Abstract][Full Text] [Related]
40. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X; Jin W
Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]